Industry
Ananda Pharma Doses First Patient in NIHR-Backed CIPN Trial
The study is evaluating MRX1, the company’s proprietary CBD-based oral solution, as a treatment for chemotherapy-induced peripheral neuropathy (CIPN).
Business of Cannabis
Latest by Business of Cannabis
News
Germany Bans Flower from Reimbursement and Mandates Six-Month Trial for Extracts
Germany has voted to ban medical cannabis flower from its statutory health insurance scheme.
News
France Submits Decree for the Reimbursement of Medical Cannabis
France’s incoming generalised medical cannabis framework has edged closer to clearing its last remaining hurdle.
Industry
Nine of the 10 Top CBPM Prescribers Are Pharmacists, UK FOI Data Shows
Pharmacist independent prescribers accounted for 61.9% of the total items prescribed between January 2019 and May 2025.
News
France Sets July Deadline for Medical Cannabis Regulations, as Study Shows Opioid Reductions
France’s medical cannabis experiment showed treatment was effective in reducing opioid use across four indications.
Industry
Ananda Pharma Confirms Safety of CBD Drug, as Clinical Pain Trials Approach
Ananda Pharma has taken another major step forward in bringing its flagship MRX1 CBD oral solution to market.
News
Do 10 Doctors Really Prescribe Half of England’s Medical Cannabis?
We take a closer look at the data behind medical cannabis prescribing to examine what it can reliably show us.
News
Vertanical Secures FDA Breakthrough Designation for Cannabis-Based Pain Drug
The development puts VER-01 in prime position to become the first FDA-approved cannabis-derived medicine for pain.
Science
Is Cannabis Effective for ADHD?
ADHD is one of the most commonly reported reasons people seek medical cannabis, but does the evidence support it?
News
Just Under Half of Brits Support Legalising Cannabis, YouGov Poll Shows
YouGov has published a representative survey examining the British public’s attitudes towards cannabis.
News
Ireland Moves Forward With Review of Medical Cannabis Programme
Less than 100 patients have been approved for medical cannabis treatment under the MCAP scheme.
News
Germany’s Cannabis Act Two Years On — What Government Data Shows
After two years of Germany’s Cannabis Act (CanG), the most comprehensive analysis of its impact to date has been published.
Science
Lancet Review of Medical Cannabis in Mental Health – What the Study Shows
Researchers concluded that the available evidence rarely justifies the routine prescribing of cannabinoids for mental health conditions.
News
Patient Protect Supports UK Medical Cannabis Patients Facing Discrimination
A new UK-wide service has launched to support medical cannabis patients who face discrimination.
News
Ananda Pharma to Begin Dosing in NHS-Backed CBD Endometriosis Trial
The company has cleared the final regulatory hurdle to begin its ENDOCAN Phase 2 trial in women with endometriosis-associated pain.
Insight
New Report: Poland Medical Cannabis Market Data Shows Full Post-Ban Recovery
Polish pharmacies dispensed nearly 5,450 kilograms of dried cannabis flower in 2025, a 12% increase from the prior year, according to new data obtained by Prohibition Partners. By October, monthly volumes […]
News
“The Narrative Needs to Change”: Inside The UK’s Cannabis Media Storm
Patients and healthcare professionals have responded to recent media coverage about medical cannabis in the UK.
News
Inside the Medical Cannabis Police Guidance: Everything Patients Need to Know
Last week, the first official guidance on medical cannabis for police officers in England and Wales was made public.
News
UK Policing Body Publishes First Official Guidance on Medical Cannabis
The National Police Chiefs’ Council has approved the first official guidance for medical cannabis.
Industry
Prescribing, Products and Patient Access: What to Expect from Medical Cannabis in 2026
The team at Prohibition Partners shares how they think things will shape up for medical cannabis in 2026.
Industry
What Is Really Going on in the UK’s Medical Cannabis Market?
In the first of a series of deep dives in the UK market, we look into its rapid growth, the shift in dominance of popular strains, and the dramatic swing towards higher THC products.
News
Early Results From Swiss Cannabis Pilot Bolster Case for Federal Legalisation
Zurich’s flagship adult-use cannabis trial, Züri Can, could now run until 2028 after city officials applied this week to extend the project by two years, citing strong early results in […]
News
‘Significant Variation in Standards’ Found Across UK Medical Cannabis Pharmacies as ACMD Review Call Closes
A new report from the General Pharmaceutical Council’s (GPhC) provides the most detailed regulatory snapshot yet of how medical cannabis is being dispensed across the UK.
News
Europe’s First ‘Whole Plant’ Cannabis Medicine Could be Available by 2026
German pharmaceutical company Vertanical believes it is on course to deliver the first ‘whole-plant’, cannabis medicine with international approval. After seven years of endeavour, and an investment of over $250m, […]